AR043006A1 - Proceso para preparar ribonucleosidos ramificados - Google Patents

Proceso para preparar ribonucleosidos ramificados

Info

Publication number
AR043006A1
AR043006A1 ARP040100318A ARP040100318A AR043006A1 AR 043006 A1 AR043006 A1 AR 043006A1 AR P040100318 A ARP040100318 A AR P040100318A AR P040100318 A ARP040100318 A AR P040100318A AR 043006 A1 AR043006 A1 AR 043006A1
Authority
AR
Argentina
Prior art keywords
compound
structural formula
pyrimidine
pyrrolo
preparation
Prior art date
Application number
ARP040100318A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR043006A1 publication Critical patent/AR043006A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Proceso para la preparación de ribonucleósidos de cadena ramificada inhibidores de la polimerasa HCV para el tratamiento de la infección HCV. Reivindicación 1: Un proceso para la preparación de un compuesto con fórmula estructural (1) donde R1 es C1-6 alquil y B es una purina o nucleobase pirimidina seleccionada entre el grupo consistente en citosina, uracilo, timina,, hipoxantina, adenina, guanina, 7-deazaguanina, 7-deazaadenina, 7-deaza-2,6-diaminopurina, y 7-deazahipoxantina; que comprende los pasos de (a) producir un compuesto de fórmula estructural (4) donde B´ es opcionalmente B protegido, mediante el contacto con un compuesto de fórmula estructural (2) donde PG es un grupo protector hidroxilo, con un nucleofilo B´ en un solvente orgánico adecuado; y (b) eliminado los grupos protectores hidroxilo PG y opcionalmente los grupos protectores en B´ Reivindicación 14: 4-amino-7-(2-C-metil-b-D-ribofuranosil)-7H-pirrolo[2,3-d]pirimidina en la forma de un solvato tolueno cristalino. Reivindicación 15: Un compuesto el cual es 4-ftalimido-7H-pirrolo[2,3-d]pirimidina.
ARP040100318A 2003-02-12 2004-02-02 Proceso para preparar ribonucleosidos ramificados AR043006A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44693503P 2003-02-12 2003-02-12

Publications (1)

Publication Number Publication Date
AR043006A1 true AR043006A1 (es) 2005-07-13

Family

ID=32869576

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100318A AR043006A1 (es) 2003-02-12 2004-02-02 Proceso para preparar ribonucleosidos ramificados

Country Status (7)

Country Link
US (1) US7339054B2 (es)
EP (1) EP1594882B1 (es)
AR (1) AR043006A1 (es)
AT (1) ATE435231T1 (es)
DE (1) DE602004021774D1 (es)
TW (1) TWI320787B (es)
WO (1) WO2004072090A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
WO2001092282A2 (en) 2000-05-26 2001-12-06 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
US7323449B2 (en) 2002-07-24 2008-01-29 Merck & Co., Inc. Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
KR20050088079A (ko) 2002-11-15 2005-09-01 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이
AR043006A1 (es) * 2003-02-12 2005-07-13 Merck & Co Inc Proceso para preparar ribonucleosidos ramificados
US20080261913A1 (en) 2006-12-28 2008-10-23 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of liver disorders
BRPI1009324A2 (pt) * 2009-03-20 2015-11-24 Alios Biopharma Inc compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
AR094621A1 (es) 2010-04-01 2015-08-19 Idenix Pharmaceuticals Inc Compuestos y composiciones farmacéuticas para el tratamiento de infecciones virales
SG188497A1 (en) 2010-09-22 2013-05-31 Alios Biopharma Inc Substituted nucleotide analogs
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
EP2755983B1 (en) 2011-09-12 2017-03-15 Idenix Pharmaceuticals LLC. Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
WO2013056046A1 (en) 2011-10-14 2013-04-18 Idenix Pharmaceuticals, Inc. Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc SUBSTITUTED PHOSPHORTHIOAT NUCLEOTIDE ANALOGUE
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
AU2013266393B2 (en) 2012-05-22 2017-09-28 Idenix Pharmaceuticals Llc D-amino acid compounds for liver disease
WO2013177195A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
EP2852604B1 (en) 2012-05-22 2017-04-12 Idenix Pharmaceuticals LLC 3',5'-cyclic phosphoramidate prodrugs for hcv infection
ES2597757T3 (es) 2012-05-25 2017-01-20 Janssen Sciences Ireland Uc Nucleósidos de uracilespirooxetano
WO2014052638A1 (en) 2012-09-27 2014-04-03 Idenix Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
US10513534B2 (en) 2012-10-08 2019-12-24 Idenix Pharmaceuticals Llc 2′-chloro nucleoside analogs for HCV infection
WO2014066239A1 (en) 2012-10-22 2014-05-01 Idenix Pharmaceuticals, Inc. 2',4'-bridged nucleosides for hcv infection
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
WO2014137926A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. 3'-deoxy nucleosides for the treatment of hcv
WO2014160484A1 (en) 2013-03-13 2014-10-02 Idenix Pharmaceuticals, Inc. Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
US9187515B2 (en) 2013-04-01 2015-11-17 Idenix Pharmaceuticals Llc 2′,4′-fluoro nucleosides for the treatment of HCV
ES2623287T3 (es) 2013-04-12 2017-07-10 Achillion Pharmaceuticals, Inc. Derivado de nucleósido altamente activo para el tratamiento del VHC
US10005779B2 (en) 2013-06-05 2018-06-26 Idenix Pharmaceuticals Llc 1′,4′-thio nucleosides for the treatment of HCV
US20150037282A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
WO2015161137A1 (en) 2014-04-16 2015-10-22 Idenix Pharmaceuticals, Inc. 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
UA124966C2 (uk) 2015-03-06 2021-12-22 Атеа Фармасеутікалс, Інк. <font face="Symbol">b</font>-D-2'-ДЕЗОКСИ-2'-<font face="Symbol">a</font>-ФТОР-2'-<font face="Symbol">b</font>-C-ЗАМІЩЕНІ-2-МОДИФІКОВАНІ-N<sup>6</sup>-ЗАМІЩЕНІ ПУРИНОВІ НУКЛЕОТИДИ ДЛЯ ЛІКУВАННЯ ВИКЛИКАНИХ HCV ЗАХВОРЮВАНЬ
LU100724B1 (en) 2016-07-14 2018-07-31 Atea Pharmaceuticals Inc Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
WO2018048937A1 (en) 2016-09-07 2018-03-15 Atea Pharmaceuticals, Inc. 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
SG11201906163TA (en) 2017-02-01 2019-08-27 Atea Pharmaceuticals Inc Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
KR20200140865A (ko) 2018-04-10 2020-12-16 아테아 파마슈티컬즈, 인크. 간경변증을 갖는 hcv 감염 환자의 치료
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19
US20220251088A1 (en) * 2020-12-10 2022-08-11 Prelude Therapeutics, Incorporated Processes for Making PRMT5 Inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037980A (en) * 1955-08-18 1962-06-05 Burroughs Wellcome Co Pyrrolopyrimidine vasodilators and method of making them
US3480613A (en) * 1967-07-03 1969-11-25 Merck & Co Inc 2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
WO2001092282A2 (en) 2000-05-26 2001-12-06 Idenix (Cayman) Limited Methods and compositions for treating flaviviruses and pestiviruses
EP2251015B1 (en) 2000-10-18 2013-02-20 Gilead Pharmasset LLC Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
SI1355916T1 (sl) * 2001-01-22 2007-04-30 Merck & Co Inc Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze
AR043006A1 (es) * 2003-02-12 2005-07-13 Merck & Co Inc Proceso para preparar ribonucleosidos ramificados
WO2006065335A2 (en) * 2004-10-21 2006-06-22 Merck & Co., Inc. Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection

Also Published As

Publication number Publication date
TW200508244A (en) 2005-03-01
US20070037771A1 (en) 2007-02-15
ATE435231T1 (de) 2009-07-15
EP1594882A1 (en) 2005-11-16
EP1594882B1 (en) 2009-07-01
TWI320787B (en) 2010-02-21
DE602004021774D1 (de) 2009-08-13
US7339054B2 (en) 2008-03-04
WO2004072090A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
AR043006A1 (es) Proceso para preparar ribonucleosidos ramificados
ES2402597T3 (es) Nucleósidos modificados para el tratamiento de infecciones víricas y proliferación celular anormal
ES2620131T3 (es) Nucleótidos marcados
PE20130807A1 (es) Metodos para la preparacion de profarmacos de fosforamidato diastereomericamente puros
PE20060607A1 (es) Derivados de indol tetraciclicos como agentes antivirales
WO2002069903A3 (en) Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
IL209917A (en) Nucleotides and Nucleosides and Their Methods for Use in DNA Flooring
PL164785B1 (en) Method of obtaining novel substituted -1,3-oxathiolanes
WO2008062206A8 (en) Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus
PL158050B1 (pl) Sposób wytwarzania 5-podstawionych nukleozydów pirymidynowych PL PL
RU96118248A (ru) 3&#39;-замещенное производное нуклеозида
IL88330A (en) 2, (3-Didhaoxy- (2-fluoronucleosides, their preparation and pharmaceutical preparations containing them)
FI90876C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten aristeromysiini/adenosiinijohdannaisten valmistamiseksi
Shin et al. Identification of 6′-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication
MY130927A (en) Anhydrous crystalline 1-(4(s)-azido-2(s), 3(r)-dihydroxy-4-(hydroxymethyl)-1(r)-cyclopentyl)cytosine hemisulfate as useful as an antiviral agent
CA2506797A1 (en) Detectable labeled nucleoside analogs and methods of use thereof
ATE496056T1 (de) Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
AU7653300A (en) Carbocyclic nucleosides and process for obtaining such
AR051338A1 (es) Procedimiento para preparar compuestos de purina
Hirama et al. Synthesis and characterization of oligodeoxynucleotides containing a novel tetraazabenzo [cd] azulene: naphthyridine base pair
JP2006248929A (ja) リボヌクレオシドの２’水酸基の脱保護方法
JP2001517659A5 (es)
EP3645546A1 (en) Chiral phosphoramidite auxiliaries and methods of their use
CA2479039A1 (en) 2,2-bis(hydroxymethyl)cyclopropylidenemethyl -purines and -pyrimidines as antiviral agents
Pei et al. Synthesis of 3′-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents

Legal Events

Date Code Title Description
FB Suspension of granting procedure